Publications

Shah MA, Shitara K, Lordick F, Bang Y-J, Tebbutt NC, Metges J-P, Muro K, Lee K-W, Shen L, Tjulandin S et al..  2022.  Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.. Clin Cancer Res. 28(17):OF1-OF9.

Shah MA, Bennouna J, Doi T, Shen L, Kato K, Adenis A, Mamon HJ, Moehler M, Fu X, Cho BChul et al..  2021.  KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma.. Future Oncol. 17(10):1143-1153.